2023 | Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes
| GUT AND LIVER |
2023 | Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis | HEPATOLOGY |
2023 | Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
| DIAGNOSTICS |
2022 | Long-term cardiovascular outcomes differ across metabolic dysfunction-associated fatty liver disease subtypes among middle-aged population | HEPATOLOGY INTERNATIONAL |
2022 | External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study
| CANCERS |
2021 | Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
| CANCERS |
2021 | Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
2020 | Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir | JOURNAL OF VIRAL HEPATITIS |
2020 | Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
| GUT AND LIVER |
2020 | Is liver biopsy still useful in the era of non-invasive tests?
| CLINICAL AND MOLECULAR HEPATOLOGY |
2020 | Establishment and Validation of a Risk Prediction Model in Patients With Hepatocellular Carcinoma Treated With Transarterial Radioembolization | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2020 | An observational study on long-term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate | JOURNAL OF VIRAL HEPATITIS |
2019 | Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database
| CANCER RESEARCH AND TREATMENT |
2019 | Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma | Journal of Vascular and Interventional Radiology |
2019 | Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
| PLOS ONE |
2019 | Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis
| JOURNAL OF CLINICAL MEDICINE |
2016 | Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients
| SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY |
2014 | 다발성 글루카곤 생성 내분비세포종을 동반한 췌장 알파세포의 Nesidioblastosis 및 과다증식 1예
| Korean Journal of Gastroenterology |
2014 | Use of the Delta Neutrophil Index as a Prognostic Factor of Mortality in Patients with Spontaneous Bacterial Peritonitis: Implications of a Simple and Useful Marker
| PLOS ONE |
2013 | Therapeutic Strategies for Well-differentiated Papillary Mesothelioma of the Peritoneum
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |